• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Acute-onset rhabdomyolysis secondary to sitagliptin and atorvastatin interaction.西他列汀与阿托伐他汀相互作用继发急性横纹肌溶解症。
Int J Gen Med. 2016 Apr 29;9:103-6. doi: 10.2147/IJGM.S98543. eCollection 2016.
2
Sitagliptin and Simvastatin Interaction Causing Rhabdomyolysis and AKI.西他列汀与辛伐他汀相互作用导致横纹肌溶解和急性肾损伤。
Case Rep Med. 2019 Feb 26;2019:2601537. doi: 10.1155/2019/2601537. eCollection 2019.
3
Rhabdomyolysis caused by a potential sitagliptin-lovastatin interaction.由西他列汀与洛伐他汀潜在相互作用引起的横纹肌溶解症。
Pharmacotherapy. 2009 Mar;29(3):352-6. doi: 10.1592/phco.29.3.352.
4
Rhabdomyolysis precipitated by possible interaction of ticagrelor with high-dose atorvastatin.替格瑞洛与大剂量阿托伐他汀可能相互作用引发的横纹肌溶解症。
J Am Pharm Assoc (2003). 2015 May-Jun;55(3):320-3. doi: 10.1331/JAPhA.2015.14151.
5
Rhabdomyolysis and AKI with Atorvastatin and Sitagliptin Use in the Setting of Low 25-Hydroxyvitamin D Levels.在 25-羟维生素 D 水平低的情况下使用阿托伐他汀和西他列汀导致横纹肌溶解和急性肾损伤。
J Gen Intern Med. 2017 Oct;32(10):1156-1159. doi: 10.1007/s11606-017-4115-x. Epub 2017 Jul 13.
6
Rhabdomyolysis causing AV blockade due to possible atorvastatin, esomeprazole, and clarithromycin interaction.横纹肌溶解症导致房室传导阻滞,可能是由于阿托伐他汀、埃索美拉唑和克拉霉素相互作用所致。
Ann Pharmacother. 2003 Jun;37(6):808-11. doi: 10.1345/aph.1C396.
7
Severe Rhabdomyolysis due to Presumed Drug Interactions between Atorvastatin with Amlodipine and Ticagrelor.阿托伐他汀与氨氯地平及替格瑞洛之间可能存在药物相互作用导致的严重横纹肌溶解症。
Case Rep Crit Care. 2017;2017:3801819. doi: 10.1155/2017/3801819. Epub 2017 May 25.
8
Rhabdomyolysis Induced by Coadministration of Fusidic Acid and Atorvastatin: A Case Report and Comprehensive Review of the Literature.夫西地酸与阿托伐他汀联用所致横纹肌溶解症:一例报告及文献综述
Case Rep Nephrol. 2017;2017:2187264. doi: 10.1155/2017/2187264. Epub 2017 Oct 8.
9
Rhabdomyolysis with concurrent atorvastatin and diltiazem.横纹肌溶解症合并阿托伐他汀与地尔硫䓬使用情况
Ann Pharmacother. 2002 Oct;36(10):1546-9. doi: 10.1345/aph.1A481.
10
Rhabdomyolysis caused by the moderate CYP3A4 inhibitor fluconazole in a patient on stable atorvastatin therapy: a case report and literature review.在接受稳定阿托伐他汀治疗的患者中,由中度CYP3A4抑制剂氟康唑引起的横纹肌溶解:一例报告及文献综述
J Clin Pharm Ther. 2016 Oct;41(5):575-8. doi: 10.1111/jcpt.12425. Epub 2016 Jul 19.

引用本文的文献

1
Effects of Hypoglycemic Agents on The Musculoskeletal System: A Comprehensive Review.降糖药物对肌肉骨骼系统的影响:综述
Drug Des Devel Ther. 2025 Jul 22;19:6235-6253. doi: 10.2147/DDDT.S517101. eCollection 2025.
2
Rosuvastatin-Induced Rhabdomyolysis as a Result of Drug Interaction With Sitagliptin: A Case Report.瑞舒伐他汀与西他列汀药物相互作用导致横纹肌溶解:一例报告
Clin Med Insights Case Rep. 2024 Sep 2;17:11795476241274162. doi: 10.1177/11795476241274162. eCollection 2024.
3
Sitagliptin and Simvastatin Interaction Causing Rhabdomyolysis and AKI.西他列汀与辛伐他汀相互作用导致横纹肌溶解和急性肾损伤。
Case Rep Med. 2019 Feb 26;2019:2601537. doi: 10.1155/2019/2601537. eCollection 2019.
4
Diabetes pharmacotherapy and effects on the musculoskeletal system.糖尿病药物治疗及其对骨骼肌肉系统的影响。
Diabetes Metab Res Rev. 2019 Feb;35(2):e3100. doi: 10.1002/dmrr.3100. Epub 2018 Dec 20.

本文引用的文献

1
The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy.临床药物基因组学实施联盟:CPIC 指南——SLCO1B1 和辛伐他汀诱导的肌肉病变。
Clin Pharmacol Ther. 2012 Jul;92(1):112-7. doi: 10.1038/clpt.2012.57. Epub 2012 May 23.
2
Rhabdomyolysis precipitated by a sitagliptin-atorvastatin drug interaction.西他列汀与阿托伐他汀药物相互作用引发的横纹肌溶解症。
Diabet Med. 2012 May;29(5):693-4. doi: 10.1111/j.1464-5491.2011.03502.x.
3
Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake.有机阴离子转运多肽 1B1:一种遗传多态性转运体,对肝脏药物摄取具有重要意义。
Pharmacol Rev. 2011 Mar;63(1):157-81. doi: 10.1124/pr.110.002857. Epub 2011 Jan 18.
4
Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial.辛伐他汀日剂量 80 毫克与 20 毫克对心肌梗死后 12064 例存活者的 LDL 胆固醇的强化降低作用:一项双盲随机试验。
Lancet. 2010 Nov 13;376(9753):1658-69. doi: 10.1016/S0140-6736(10)60310-8. Epub 2010 Nov 8.
5
Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia.瑞舒伐他汀在血脂异常临床治疗中的不良反应及药物相互作用。
Am J Cardiovasc Drugs. 2010;10(1):11-28. doi: 10.2165/13168600-000000000-00000.
6
Impact of OATP transporters on pharmacokinetics.有机阴离子转运多肽(OATP)转运体对药代动力学的影响。
Br J Pharmacol. 2009 Oct;158(3):693-705. doi: 10.1111/j.1476-5381.2009.00430.x. Epub 2009 Sep 25.
7
Rhabdomyolysis caused by a potential sitagliptin-lovastatin interaction.由西他列汀与洛伐他汀潜在相互作用引起的横纹肌溶解症。
Pharmacotherapy. 2009 Mar;29(3):352-6. doi: 10.1592/phco.29.3.352.
8
Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use.与使用西他列汀和辛伐他汀相关的肾衰竭和横纹肌溶解症。
Diabet Med. 2008 Oct;25(10):1229-30. doi: 10.1111/j.1464-5491.2008.02536.x.
9
effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers.OATP1B转运体抑制对健康志愿者中阿托伐他汀药代动力学的影响。
Clin Pharmacol Ther. 2007 Feb;81(2):194-204. doi: 10.1038/sj.clpt.6100038. Epub 2006 Dec 27.
10
SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid.SLCO1B1基因多态性显著影响辛伐他汀酸的药代动力学。
Pharmacogenet Genomics. 2006 Dec;16(12):873-9. doi: 10.1097/01.fpc.0000230416.82349.90.

西他列汀与阿托伐他汀相互作用继发急性横纹肌溶解症。

Acute-onset rhabdomyolysis secondary to sitagliptin and atorvastatin interaction.

作者信息

Khan Muhammad Waqas, Kurian Saji, Bishnoi Rohit

机构信息

Division of Hospital Medicine, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.

College of Pharmacy, University of Florida, Gainesville, FL, USA.

出版信息

Int J Gen Med. 2016 Apr 29;9:103-6. doi: 10.2147/IJGM.S98543. eCollection 2016.

DOI:10.2147/IJGM.S98543
PMID:27199569
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4857828/
Abstract

Rhabdomyolysis is a serious medical condition in which the skeletal muscle tissue gets damaged and breaks down at rapid rates, potentially leading to death if not managed early on. Rhabdomyolysis in adults has several etiologies such as crush injuries, prolonged immobilization, strenuous exercise, hormonal or metabolic causes, infections, and drug-drug interactions. We present a case report of the interaction of two drugs that are used commonly in the general population. We here discuss a case of a 60-year-old female who presented to the hospital with complaints of generalized weakness, muscle aches, and atypical chest pain for a week after her primary care physician started her on sitagliptin while she was already on atorvastatin. After review of literature, this is the second known case of such an interaction causing acute breakdown of skeletal musculature.

摘要

横纹肌溶解症是一种严重的医学病症,其中骨骼肌组织受损并迅速分解,如果不及早处理,可能会导致死亡。成人横纹肌溶解症有多种病因,如挤压伤、长期制动、剧烈运动、激素或代谢原因、感染以及药物相互作用。我们报告一例普通人群中常用的两种药物相互作用的病例。在此,我们讨论一名60岁女性的病例,她在初级保健医生给她开了西他列汀,而她当时已经在服用阿托伐他汀的情况下,因全身无力、肌肉疼痛和非典型胸痛一周后前来就诊。查阅文献后发现,这是已知的第二例此类相互作用导致骨骼肌急性分解的病例。